{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:23:26Z","timestamp":1771464206030,"version":"3.50.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:00:00Z","timestamp":1434931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131086","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T18:18:29Z","timestamp":1434997109000},"page":"e0131086","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Zhengxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.ATV.0000191633.52585.14","article-title":"Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers","volume":"26","author":"D Rothenbacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(10)61414-6","article-title":"Raising the priority of preventing chronic diseases: a political process","volume":"376","author":"R Geneau","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"R Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e45907","DOI":"10.1371\/journal.pone.0045907","article-title":"Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease","volume":"7","author":"D Rothenbacher","year":"2012","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2007.02.012","article-title":"Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease","volume":"124","author":"T Inoue","year":"2008","journal-title":"Int J Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/CRD.0000000000000022","article-title":"Interleukin 1beta: a proinflammatory target for preventing atherosclerotic heart disease","volume":"22","author":"S McCarty","year":"2014","journal-title":"Cardiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"C Garlanda","year":"2013","journal-title":"Immunity"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"JE Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"D Boraschi","year":"2013","journal-title":"Semin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e5073","DOI":"10.1371\/journal.pone.0005073","article-title":"Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding","volume":"4","author":"J Chamberlain","year":"2009","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"MR Alexander","year":"2012","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1253\/circj.CJ-08-1150","article-title":"A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis","volume":"73","author":"PS Olofsson","year":"2009","journal-title":"Circ J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvp241","article-title":"Interleukin 8 and cardiovascular disease","volume":"84","author":"S Apostolakis","year":"2009","journal-title":"Cardiovasc Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1161\/01.ATV.0000235691.84430.86","article-title":"Chemokines and incident coronary heart disease: results from the MONICA\/KORA Augsburg case-cohort study, 1984\u20132002","volume":"26","author":"C Herder","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6750-12-8","article-title":"A designer hyper interleukin 11 (H11) is a biologically active cytokine","volume":"12","author":"H Dams-Kozlowska","year":"2012","journal-title":"BMC Biotechnol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"H569","DOI":"10.1152\/ajpheart.00060.2012","article-title":"Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart","volume":"303","author":"M Obana","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1beta as the gatekeeper of inflammation","volume":"41","author":"CA Dinarello","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI61163","article-title":"IL-1 and atherosclerosis: a murine twist to an evolving human story","volume":"122","author":"DJ Rader","year":"2012","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"CA Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.1300725","article-title":"IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium","volume":"191","author":"A Saxena","year":"2013","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/01.CIR.0000125700.33637.B1","article-title":"Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors","volume":"109","author":"T Waehre","year":"2004","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/ATVBAHA.113.302700","article-title":"Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans","volume":"34","author":"LM Beaulieu","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice","volume":"216","author":"V Bhaskar","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"PM Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"16214","DOI":"10.1074\/jbc.M114.571505","article-title":"3-Hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin)-induced 28-kDa interleukin-1beta interferes with mature IL-1beta signaling","volume":"289","author":"F Davaro","year":"2014","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"P Duewell","year":"2010","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"K Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1742-2094-9-102","article-title":"Telmisartan directly ameliorates the neuronal inflammatory response to IL-1beta partly through the JNK\/c-Jun and NADPH oxidase pathways","volume":"9","author":"T Pang","year":"2012","journal-title":"J Neuroinflammation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2362.1997.1270667.x","article-title":"Neutrophil superoxide release and interleukin 8 in acute myocardial infarction: distinction between complicated and uncomplicated states","volume":"27","author":"K Riesenberg","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2013.12.170","article-title":"Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program","volume":"172","author":"IM Velasquez","year":"2014","journal-title":"Int J Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.111.078436","article-title":"Endothelial cells overexpressing interleukin-8 receptors reduce inflammatory and neointimal responses to arterial injury","volume":"125","author":"D Xing","year":"2012","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.109.893677","article-title":"Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction","volume":"121","author":"M Obana","year":"2010","journal-title":"Circulation"},{"key":"ref33","first-page":"3786","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","volume":"117","author":"P Gasse","year":"2007","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4049\/jimmunol.180.2.1169","article-title":"Cigarette smoke-induced pulmonary inflammation is TLR4\/MyD88 and IL-1R1\/MyD88 signaling dependent","volume":"180","author":"E Doz","year":"2008","journal-title":"J Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:30:36Z","timestamp":1589038236000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131086"}},"subtitle":[],"editor":[{"given":"Carmen","family":"Infante-Duarte","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131086","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}